Albupad Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.54M

  • Investors
  • 9

Albupad General Information

Description

Developer of albumin-based biomaterials designed for safer and more effective biomedical applications such as drug delivery and tissue engineering. The company develops and commercializes albumin-derived biomaterial technologies that support controlled drug release, biological integration, and improved therapeutic performance for use in pharmaceutical, regenerative medicine, and healthcare product applications, enabling clients for development of safer therapeutic and regenerative treatments using albumin-based biomaterials.

Contact Information

Website
www.albupad.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 32 Allée de la Robertsau
  • 67000 Strasbourg
  • France
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 32 Allée de la Robertsau
  • 67000 Strasbourg
  • France

Albupad Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Albupad Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC 03-Mar-2026 $1.54M Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator 19-Feb-2024 Completed Generating Revenue
1. University Spin-Out 19-Feb-2024 Completed Generating Revenue
To view Albupad’s complete valuation and funding history, request access »

Albupad Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Albupad Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alsace Business Angels Angel Group Minority
Bpifrance Sovereign Wealth Fund Minority
Key Ventures Venture Capital Minority
Yeast (France) Angel Group Minority
Quest for Health Accelerator/Incubator
You’re viewing 5 of 9 investors. Get the full list »

Albupad FAQs

  • When was Albupad founded?

    Albupad was founded in 2024.

  • Where is Albupad headquartered?

    Albupad is headquartered in Strasbourg, France.

  • What is the size of Albupad?

    Albupad has 5 total employees.

  • What industry is Albupad in?

    Albupad’s primary industry is Drug Delivery.

  • Is Albupad a private or public company?

    Albupad is a Private company.

  • What is Albupad’s current revenue?

    The current revenue for Albupad is .

  • How much funding has Albupad raised over time?

    Albupad has raised $1.54M.

  • Who are Albupad’s investors?

    Alsace Business Angels, Bpifrance, Key Ventures, Yeast (France), and Quest for Health are 5 of 9 investors who have invested in Albupad.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process